Cameron Santoro is an associate editor for The American Journal of Managed Care® (AJMC®), AJMC.com, and The Center for Biosimilars®.
Strategies to Address Veteran Health Disparities Beyond the Battlefield
May 30th 2025Despite their profound sacrifices, veterans and active military members disproportionately face significant physical and mental health issues stemming from their service, with many struggling to access the affordable and comprehensive care they need.
Pediatric Hidradenitis Suppurativa Linked to Gut Microbiome Dysregulation, Mental Health Connections
May 28th 2025Significant differences in gut microbiome composition were found among pediatric patients with hidradenitis suppurativa, suggesting further investigation surrounding gut microbiome dysregulation.
Future of Vitiligo Treatment: Emerging Therapies, Impact on Quality of Life
May 28th 2025Patients with vitiligo experience impacts on quality of life, emerging therapies offer promising prospects for more targeted and effective treatments, though further research is needed to confirm their safety, efficacy, and optimal use.
The Argument Against Routine Antibiotics for Patients With Nonsevere COVID-19
May 19th 2025Over 500,000 US patients hospitalized with nonsevere COVID-19 saw no clinically significant benefit and potential harm associated with routine early antibiotic treatment, supporting antibiotic stewardship to limit unnecessary use.
Empowering Women's Health: Integrated Care and Education With Jessica Horwitz, MPH, FNP-C
May 16th 2025Jessica Horwitz, MPH, FNP-C, emphasizes the importance of accessible preventive care and health education, the interconnectedness of mental and physical well-being, and the need for women, providers, and policymakers to prioritize comprehensive and depoliticized women's health care.
Addressing Intersectionality in Women's Health: An Interview With Jessica Horwitz, MPH, FNP-C
May 15th 2025Jessica Horwitz, MPH, FNP-C, highlighted the crucial need for public health professionals and health care providers to address the intersectionality of women's health by acknowledging diverse experiences and ensuring equitable, coordinated care that goes beyond physical health.
Depoliticizing and Prioritizing Comprehensive Women's Health: Jessica Horwitz, MPH, FNP-C
May 14th 2025Jessica Horwitz, MPH, FNP-C, advocated leveraging Women's Health Week to promote comprehensive and depoliticized women's health care, destigmatizing pelvic floor health, and integrating mental health into primary care.
A Patient-Centered Approach to Health Equity: Eboni Price-Haywood, MD, and Toni Flowers, PhD
May 13th 2025Eboni Price-Haywood, MD, MPH, MMM, Xavier Ochsner College of Medicine, and Toni Flowers, PhD, DHL, MBA, LCMC Health, advocate for understanding individual patient circumstances, ultimately leading to more comprehensive and effective outcomes.
Pediatric Food Allergy Diagnosis Could Be Streamlined By New Scoring System
May 10th 2025A newly developed Naples Pediatric Food Allergy grading scale, incorporating clinical history and examination, shows promise in streamlining the diagnosis of food allergies in children, potentially reducing delays and health care burdens.
Black Youths Overlabeled High Risk in Mental Health Emergencies
May 9th 2025Despite similar scores on an aggression risk evaluation tool in a pediatric emergency department, Black youths were significantly more likely to be labeled with a high aggression risk behavioral health flag in their electronic health records compared with White youths.
Dermatology Impacts Climate Change With High Carbon Emissions, Path to Sustainability
May 7th 2025There are significant environmental impacts of dermatological practices that call for interdisciplinary collaboration and policy changes to promote sustainability and reduce carbon emissions within the field.
Study Highlights Unmet Needs in Measuring Patient Experiences in Alopecia Areata
April 29th 2025Significant unmet needs were found among high-quality validation studies on the internal structure of patient-reported outcome measures (PROMs) specific to alopecia areata (AA), a common hair loss condition with substantial quality of life impacts.
FDA Greenlights Dupilumab for Chronic Spontaneous Urticaria, Marking First Approval in a Decade
April 18th 2025Marking the first approval in over a decade for this challenging condition, the FDA has approved dupilumab (Dupixent) to treat chronic spontaneous urticaria in patients 12 years and older whose hives and itching remain uncontrolled by antihistamines.
Lebrikizumab Shows Promise in Long-Term Atopic Dermatitis Control: Raj Chovatiya, MD, PhD
April 15th 2025Raj Chovatiya, MD, PhD, MSCI, highlights the long-term effectiveness of lebrikizumab across diverse patients, including those with prior biologic use, positioning it as a potential first-line treatment for moderate to severe atopic dermatitis.
Significant Disease Burden and Management Issues in Chronic Spontaneous Urticaria
April 15th 2025Patients with chronic spontaneous urticaria experienced a long delay in diagnosis, a substantial impact on their quality of life, and often received inadequate treatment, highlighting the need for better management and understanding of the condition.